The Effects of Dual Antiplatelet Therapy on the Occurrence of Recurrent Cardiovascular Events After Myocardial Infarction in Obese Patients
Introduction. Acute myocardial infarction (AMI) with ST elevation (STEMI) is still the main cause of mortality and invalidisation of ablebodied population. Regardless of the primary percutaneous coronary intervention (PCI) or thrombolysis, dual antiplatelet therapy (DAPT) remains the main therapeut...
Main Authors: | Borovyk K., Rindina N., Kravchun P., Tabachenko O., Yermak O., Romanyuk M. |
---|---|
Format: | Article |
Language: | English |
Published: |
Publishing House "Kyrylytsya"
2019-04-01
|
Series: | Львівський клінічний вісник |
Subjects: | |
Online Access: | http://lkv.biz/the-effects-of-dual-antiplatelet-therapy-on-the-occurrence-of-recurrent-cardiovascular-events-after-myocardial-infarction-in-obese-patients/ |
Similar Items
-
Clopidogrel in the treatment of patients with ST-elevation acute myocardial infarction: state-of-art in 2013
by: O. V. Averkov
Published: (2013-02-01) -
PROLONGED DUAL ANTIPLATELET THERAPY AFTER MYOCARDIAL INFARCTION: WHAT THE RESULTS OF THE PEGASUS-TIMI 54 TRIAL SHOW
by: I. S. Yavelov
Published: (2017-09-01) -
Patient after myocardial infarction: how to reduce the risk of recurrent ischemic events?
by: O. L Barbarash, et al.
Published: (2015-06-01) -
Ticagrelor versus clopidogrel in the management of acute myocardial infarction
by: Candice Volney, et al.
Published: (2019-07-01) -
Dual Antiplatelet Therapy in Coronary Artery Disease
by: Raghav Sharma, et al.
Published: (2020-08-01)